🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
9-ING-41 has anti-cancer clinical activity with no significant toxicity in ...
Status
Terminated
Location
University of California, San Francisco
Start Date
2020-06-05
Trial ID
NCT04239092
Treatments Being Tested
To evaluate the efficacy and safety of compound preparation Biolosion in co...
Status
Recruiting
Location
Gansu Cancer Hospital
Start Date
2026-04-01
Trial ID
NCT06768931
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and response of c...
Status
Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2023-10-12
Trial ID
NCT05833763
Treatments Being Tested
This randomized, double-blind, placebo-controlled, parallel-group study aim...
Status
Recruiting
Location
Department of Sports Dietetics, Poznan University of Physical Education Poznań
Start Date
2023-10-01
Trial ID
NCT07092930
This trial is a randomized, double-blind, placebo-controlled, parallel-grou...
Status
Completed
Location
University of California Irvine Medical Center
Start Date
2021-09-16
Trial ID
NCT04880642
RATIONALE: Drugs used in chemotherapy, such as bendamustine hydrochloride, ...
Status
Completed
Location
Marin Cancer Care Inc
Start Date
2011-02-09
Trial ID
NCT01216683
Treatments Being Tested
Phase 1 study to evaluate the safety and tolerability of selinexor and dete...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2012-06-18
Trial ID
NCT01607905
Treatments Being Tested
The purpose of this study is to assess the effect of C21 on forearm blood f...
Status
Completed
Location
Clinical Trial Consultants AB
Start Date
2022-04-28
Trial ID
NCT05277922
Treatments Being Tested
This is a single center, open-label, phase I trial with a standard 3+3 dose...
Status
Completed
Location
National Cancer Centre Singapore
Start Date
2016-07-01
Trial ID
NCT03212937
Treatments Being Tested
In the phase I part, to determine the recommended doses (RD) and dosing reg...
Status
Active Not Recruiting
Location
UCLA Medical Center
Start Date
2024-08-14
Trial ID
NCT06247995
Treatments Being Tested